PuSH - Publication Server of Helmholtz Zentrum München: A genetic screen for modifiers of the delta1-dependent notch signalling function in the mouse.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Rubio-Aliaga, I.* ; Soewarto, D.* ; Wagner, S.* ; Klaften, M. ; Fuchs, H. ; Kalaydjiev, S. ; Busch, D.H. ; Klempt, M.* ; Rathkolb, B. ; Wolf, E. ; Abe, K.* ; Zeiser, S.* ; Przemeck, G.K.H. ; Beckers, J. ; Hrabě de Angelis, M.

A genetic screen for modifiers of the delta1-dependent notch signalling function in the mouse.

Vortrag: 19th Mouse Molecular Genetics Meeting, 5-9 September 2007, Hinxton/Cambridge, UK. (2007)

Abstract
Metrics
Extra information

The Notch signalling pathway is an evolutionarily conserved transduction pathway involved in embryonic patterning and regulation of cell fates during development. Recent studies have demonstrated that this pathway is integral to a complex system of interactions, which are also involved in distinct human diseases. Delta1 is one of the known ligands of the Notch receptors. Mice homozygous for a loss-of-function allele of the Delta1 gene (Dll1^lacZ/lacZ) die during embryonic development. Here, we present the results of two phenotype-driven modifier screens. Heterozygous Dll1^lacZ knockout animals were crossed with ENU-mutagenized mice and screened for dysmorphological, clinical chemical, and immunological variants that are dependent on the Delta1 loss-of-function allele. First, we show that mutagenized heterozygous Dll1^lacZ offspring have reduced body weight and altered specific clinical chemical parameters, including changes in metabolites and electrolytes relevant for kidney function. In our mutagenesis screen we have successfully generated 35 new mutant lines. Of major interest are 7 mutant lines that exhibit a Dll1^lacZ/+-dependent phenotype. These mutant mouse lines provide excellent in vivo tools for studying the role of Notch signalling in kidney and liver function, cholesterol and iron metabolism, cell-fate decisions, and during maturation of T cells in the immune system.